Financial Statements · Financial Reporting
Tabatt Pharmaeconomics OÜ
Official identifier 16021375Record date 14 Mar 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 15 Mar 2024
- Submitted date
- 14 Sep 2025
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 2,674,106 |
| Balance sheet | Cash and cash equivalents | 312,722 |
| Balance sheet | Current assets | 1,442,424 |
| Balance sheet | Current liabilities | 84,108 |
| Balance sheet | Equity | 2,589,998 |
| Balance sheet | Share capital at nominal value | 10,000 |
| Balance sheet | Non-current assets | 1,231,682 |
| Balance sheet | Retained earnings (loss) from previous periods | 885,034 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -28,360 |
| Income statement scheme 1 | Revenue | 39,474 |
| Income statement scheme 1 | Annual period profit / loss | 356,621 |
| Income statement scheme 1 | Operating profit (loss) | 335,532 |
| Income statement scheme 1 | Profit (loss) before income tax | 356,621 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 885,034 |
| Note: Labour costs | Employees | 0 |
| Note: Labour costs | Labour costs | 0 |
Linked company
Company: Tabatt Pharmaeconomics OÜ